(Q80442031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Chung J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Brass EP

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ulrich RG

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hiatt WR

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

6 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

243-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Statin-associated myopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Statin myotoxicity is associated with changes in the cardiopulmonary function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Toxicity of statins on rat skeletal muscle mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Simvastatin induces impairment in skeletal muscle while heart is protected.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Statin-associated myopathy with normal creatine kinase levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Determinants of oxygen uptake. Implications for exercise testing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Maximum rate of oxygen uptake by human skeletal muscle in relation to maximal activities of enzymes in the Krebs cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Presymptomatic neuromuscular disorders disclosed following statin treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Genetic risk factors associated with lipid-lowering drug-induced myopathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Aerobic metabolism of human quadriceps muscle: in vivo data parallel measurements on isolated mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Human skeletal muscle mitochondrial capacity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Global analysis of RNA expression profile in human vascular cells treated with statins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Factors affecting the components of the alveolar CO2 output-O2 uptake relationship during incremental exercise in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Assessment of energy expenditure and fuel utilization in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

A new method for detecting anaerobic threshold by gas exchange

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Catecholamine response during 12 days of high-altitude exposure (4, 300 m) in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Immunoassay of Insulin Using a Two-Antibody System

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100264

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554242%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference